MARKET PULSE-Intercept Pharma, Exxon, Google, Macy's, Amag

Thu Jan 9, 2014 1:39pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter,

U.S. stocks dipped on Thursday, weighed by Exxon Mobil and retailers, as an earlier boost from upbeat labor market data lost steam. Dow Jones industrial average futures were down 0.23 percent at 16,370, S&P 500 futures were down 0.03 percent at 1,832 and Nasdaq 100 futures were down 0.47 percent at 3,548.

** INTERCEPT PHARMACEUTICALS INC, $283.35, +291.42 pct

The company's drug to treat liver disease caused by fat buildup was found effective in a trial, paving the way for it to become the first approved treatment for the chronic condition.

** EXXON MOBIL CORP, $99.51, -1.22 pct

Citigroup cut its rating on the oil company's stock to "neutral" to "buy."